CCR1 and myeloid sarcoma: In animal models of MS, it was shown that CCR1-deficient animals developed a less severe disease (43), while CCR2-deficient mice were completely resistant to disease induction (44, 45), highlighting the importance of signaling through these chemokine receptors for disease initiation.